08:00 - 09:00

Registration, networking and exhibition visits

09:00 - 09:10


  • Welcome and introduction

    Gwyn Tudor

09:10 - 10:00

Plenary session


    Faraz Khan
    Seed Ventures
    Social Entrepreneur & Investor

    Ian Campbell
    Innovate UK
    Director - Health and Life Sciences

    Michael Graz
    Neem Biotech
    Managing Director

10:00 - 10:30

Refreshment break, networking and exhibition visits

10:30 - 11:30

Clinical Innovation Beyond Borders

How can clinicians and scientists reach out to patients with their innovations? The session will explore the struggles we face bringing ideas to our patients in our national and international communities, when we work outside business and industry.

  • Chair

    Judith Hall OBE
    Cardiff University, Cardiff & Vale UHB, Bill Mapleson Centre
    Professor and Consultant Anaesthetist

  • Jim Roberts
    The Royal National Throat Nose and Ear Hospital, UCLH
    Consultant Anaesthetist and the Clinical Lead for Anaesthesia

    Jenna Bowen
    Cotton Mouton Diagnostics

    Faraz Khan
    Seed Ventures
    Social Entrepreneur & Investor

10:30 - 11:30

Early Patient Access to Medicines and Therapies

The important debate around patient access to new medicines and therapies. The clinical development process and the benefits of a streamlined approach to allow innovation in treatments.

  • Chair

    Michael Graz
    Neem Biotech
    Managing Director

  • Graham Dixon
    Neem Biotech
    Chief Operating Officer

    Alison Evans
    Alzheimer's Research UK
    Head of Policy and Impact

    Professor Steven Bain
    Diabetes Research Network, Wales
    Assistant Medical Director for Research & Development for ABMUHB and Clinical Lead

    Emma Hughes
    Genetic Alliance UK
    Genetic Alliance Officer

    Angelo Micciche
    Cystic Fibrosis Trust
    Patient Representative

10:30 - 11:30

MHRA Regulatory Update

The latest developments regarding the medical device and IVD directives. Discussing the impact on your business and the management of innovation within these new directives.

  • Chair

    John Wilkinson
    Director of Devices

  • Phil Brown
    Director, Technical & Regulatory

    Peter Rose
    Managing Director, Europe

11:30 - 12:30

Successful Strategies for Innovation Adoption in Healthcare

The new Industrial strategy and the role of the AHSN’s in supporting industry to make progress in NHS adoption is also significant news for the sector.

  • Chair

    Karen Livingstone
    Eastern Academic Health Science Network
    National Director of SBRI Healthcare and Director of Industry Engagement

    AHSNs – creating Innovation Exchanges to achieve accelerated access for innovations

  • Clare Woods
    NIHR - National Institute for Health Research
    Business Development Officer 

    Glyn Barnes
    Marketing Specialist

    Sam Thwaites
    Sales Manager

    Every Patient Monitored – Advanced wireless and digital methods for improving patient safety

    Joel Gibbard
    Open Bionics

11:30 - 12:30

New Developments in Pharma Manufacturing & The Immunotherapy Revolution

Discussing the inherent risks and affordability issues which come with advanced therapies and innovation.


    Justin John
    Cardiff Medicentre
    Business Innovation Officer

    Harvey Branton
    Centre for Process Innovation
    Head of Technology

    Charles Heise
    Subject Matter Expert in Primary Separations and Filtration

    Adrian Dawkes
    PharmaVentures Ltd
    Managing Director

    Tony Sedgwick
    The Thought Disruptor

    Tony Jones
    One Nucleus

11:30 - 12:30

Delivering Diagnostics and Biomarker Discovery for the NHS and Healthcare Markets

The key diagnostic challenges faced by the NHS in a domestic as well as global health context.

  • Chair

    Nigel Silman
    Public Health England
    Senior Business Development Manager

  • Dr Tamas Szakmany
    Cardiff University
    Director of Critical Illness Research

    Paul Davis
    Chief Scientific Officer

    Cooperating to solve the key diagnostic challenges of the NHS

    Ian Bond
    Bond Digital Health

    Karen Whiting
    BBI Solutions
    Head of New Product Development

12:30 - 13:30

Lunch break, networking and exhibition visits

13:30 - 14:30

Plenary session


    Tal Golesworthy
    Technical Director

    The PEARS Project: Multidisciplinary Innovation in CardioThoracic Surgery

    Dr Helen Meese
    Institution of Mechanical Engineers
    Head of Healthcare

    Engineering Solutions for the NHS: Raising the Profile of Clinical Engineering in our Hospitals

    John Wilkinson
    Director of Devices

    The new MDR/IVDR- from words to action

14:30 - 15:30

UK Procurement Landscape and Market Access

2018 brings significant new initiatives to identify, assess and drive adoption of innovation. At the same time procurement in NHS England is implementing a new centralised model to support greater aggregation of demand and product rationalisation. Two competing forces or an alignment of process to deliver better value? This seminar will also discuss the impact of new developments in the devolved healthcare systems in Scotland and Wales around 'Value Based Procurement’.

  • Chair

    Andrew Davies
    Market Access Director

  • Naomi Chapman
    NHS Clinical Evaluation Team, Department of Health
    Clinical Programme Lead/Deputy Chief Nurse

    Mirella Marlow
    National Institute for Health and Care Excellence
    Programme Director

    Susan Myles PhD
    Health Technology Wales

14:30 - 15:30

AI and Psychology of Cancer

How digital innovation can transform the patient and public experience of healthcare in Wales and the UK. Developing the concept of ‘precision psychology’ and enhancing the concept of co-production. Using techniques such as artificial intelligence, virtual and augmented reality, chat bots and apps.

  • Chair

    Phil Webb
    Velindre NHS Trust
    Associate Director of Planning, Performance and Innovation

  • Dr Anne Johnson
    Velindre Cancer Centre
    Clinical Psychologist

    Glenn Hapgood
    Business Development Manager

    Dr Mark Taubert
    Velindre Cancer Centre
    Consultant Lead in Palliative Care

    Geoff Rollason
    Pfizer UK
    Patient Experience & Service Director Oncology

    David Clarkson
    Client Executive - Healthcare

14:30 - 15:30

Innovation Showcase

Showcasing innovative companies and products from across the UK.

  • Chair

    Mark Bowman

  • Chris May
    Managing Director

    James Rudolf
    Chief Operating Officer

    Andrew Mearns Spragg

    James Hindley
    Indoor Biotechnologies
    Executive Director

    Innovative Products for Allergy Research

    Michael Linskey

    Butterfly - Your Thyroid Diary

    Angus Hughes
    Digital Algorithms

15:30 - 16:00

Refreshment break, networking, exhibition visit

16:00 - 17:00

Finance, Funding & Brexit

Support and advice for business growth, investment and funding for research and development.

  • Chair

    Melanie Goward
    Maven Capital Partners
    Investment Director

  • Dayne Hodgson
    RedKnight Consultancy

    Richard Thompson
    Development Bank of Wales
    Technology Venture Senior Investment Executive

    Richard Bowles
    Relationship Director

    Chris Geary
    Innovate UK
    Innovation Lead, Digital Health

    Laura Collister
    BioIndustry Association
    Brexit Lead

    Andrew Evans
    Partner & Team Leader, Life Sciences

17:00 - 19:00

Event close and drinks reception
Sponsored by Neem Biotech

Please be aware that speakers and timings may change prior to the event.